Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female adolescents ages 13-17~* Current diagnosis of Major Depressive Disorder as determined by the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-PL), Children's Depression Rating Scale (CDRS-R) raw score \> 45 (T-score \> 65) at baseline~* Estimated full scale IQ \> 80 as determined by the Wechsler Intelligence Scale for Children (WISC)~* Able to receive outpatient care~* Willing to discontinue other psychosocial treatments~* Not taking psychotropic medications in the one month prior to consent, with the exception of psychostimulant medication prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD)~Exclusion Criteria:~* Current or past diagnosis of bipolar, schizophrenia, schizophreniform, schizoaffective disorders, or psychosis not otherwise specified~* Current diagnosis of developmental disorder, severe conduct disorder, life-threatening anorexia, obsessive-compulsive disorder, or autism-spectrum disorders~* Taking psychotropic medications prior to entry~* Estimated IQ \< 80~* Alcohol/drug dependence or abuse within the last 3 months~* Potential/confirmed neurological disorder or epilepsy~* Claustrophobia~* Presence of a medical condition that precludes fMRI~* Endorsement of imminent and serious suicidality~* Medical conditions for which treatment with fluoxetine is contraindicated or that take precedence over the presence of major depressive disorder (MDD)~* Pregnancy

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Behavioral Activation (Type: EXPERIMENTAL): None
- Fluoxetine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).